Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery

Rachel R. Hartman; Uday B. Kompella

doi:10.1089/jop.2017.0121

journal article Mar 01, 2018

Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery

Rachel R. Hartman Uday B. Kompella

Journal of Ocular Pharmacology and Therapeutics Vol. 34 No. 1-2 pp. 141-153 · SAGE Publications

View at Publisher Save 10.1089/jop.2017.0121

Topics

No keywords indexed for this article. Browse by subject →

References

85

[1]

Periocular routes for retinal drug delivery

Swita Raghava, Makena Hammond, Uday B Kompella

Expert Opinion on Drug Delivery 10.1517/17425247.1.1.99

[2]

10.1007/bf01977971

[3]

10.1001/archophthalmol.2010.19

[4]

10.1097/iio.0000000000000062

[5]

Williams G.A. Rev. Ophthalmol. (2014)

[6]

Wilson M.E. (2013)

[7]

10.1097/iae.0000000000000399

[8]

Rivera A.M. Acta Anaesthesiol. Belg. (2005)

[9]

10.1089/jop.2010.0082

[10]

10.1016/j.ijmecsci.2012.09.014

[11]

10.1016/s1090-3801(99)90187-8

[12]

10.1097/iae.0b013e3181b094cf

[13]

10.1016/j.ijpharm.2005.09.022

[14]

10.1097/00006982-200410001-00002

[15]

10.1111/ceo.12026

[16]

Karth P.A. Rev. Opthalmol. (2014)

[17]

10.4103/2320-3897.174429

[18]

10.1001/archophthalmol.2011.370

[19]

Doshi R.R. Retina (2012)

[20]

10.1001/archophthalmol.2011.227

[21]

10.1517/14656560903081752

[22]

10.1001/archophthalmol.2009.304

[23]

10.1016/j.ophtha.2012.02.014

[24]

10.1016/j.ajo.2015.04.013

[25]

10.1089/jop.2012.0144

[26]

Lopez R. Invest. Ophthalmol. Vis. Sci. (1987)

[27]

10.3727/000000001783986710

[28]

10.1038/eye.1989.4

[29]

Wongpichedchai S. Invest. Ophthalmol. Vis. Sci. (1992)

[30]

10.1016/0165-0270(92)90025-9

[31]

10.1007/s00417-007-0718-y

[32]

10.1167/iovs.08-2908

[33]

Petersen-Jones S.M. Mol. Vis. (2009)

[34]

10.1126/scitranslmed.3002103

[35]

10.1016/s0140-6736(16)30371-3

[36]

10.1007/s11095-010-0271-y

[37]

10.1007/s11095-008-9756-3

[38]

10.1007/978-1-4419-9920-7_14

[39]

Prausnitz M.R.A. (2015)

[40]

Andino R.V.G. (2015)

[41]

Eaton A.M. Invest. Ophthalmol. Vis. Sci. (2015)

[42]

Eaton A.M. Retina Today (2012)

[43]

10.1016/j.addr.2012.04.005

[44]

10.1159/000336045

[45]

10.1073/pnas.0807027105

[46]

10.1089/hum.2009.086

[47]

10.1056/nejmc0903652

[48]

10.1167/iovs.14-15895

[49]

10.1089/hum.2008.107

[50]

10.1056/nejmcibr1007685

Showing 50 of 85 references

Cited By

86

Gene therapy for wet AMD: a paradigm shift in the standard of care

Samuel Asanad, David S. Boyer · 2025

Expert Opinion on Emerging Drugs

Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders

Christian T. Rutan Woods, Mustafa S. Makia · 2024

Nature Communications

A New Generation of Gene Therapies as the Future of Wet AMD Treatment

Janusz Blasiak, Elzbieta Pawlowska · 2024

International Journal of Molecular...

Metrics

86

Citations

85

References

Details

Published: Mar 01, 2018
Vol/Issue: 34(1-2)
Pages: 141-153
License: View

Authors

R

Rachel R. Hartman

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

U

Uday B. Kompella

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Cite This Article

Rachel R. Hartman, Uday B. Kompella (2018). Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery. Journal of Ocular Pharmacology and Therapeutics, 34(1-2), 141-153. https://doi.org/10.1089/jop.2017.0121

Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery

You May Also Like